Fresenius Medical Care AG (FRA:FME)

Fresenius Medical Care AG Statistics

Total Valuation

FRA:FME has a market cap or net worth of EUR 14.76 billion. The enterprise value is 25.67 billion.

Market Cap	14.76B
Enterprise Value	25.67B

Important Dates

The next estimated earnings date is Tuesday, August 5, 2025.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	May 23, 2025

Share Statistics

Current Share Class	293.41M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	209.46M

Valuation Ratios

The trailing PE ratio is 23.88 and the forward PE ratio is 13.39.

PE Ratio	23.88
Forward PE	13.39
PS Ratio	0.76
PB Ratio	0.95
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.04, with an EV/FCF ratio of 15.01.

EV / Earnings	41.52
EV / Sales	1.32
EV / EBITDA	8.04
EV / EBIT	14.98
EV / FCF	15.01

Financial Position

The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.70.

Current Ratio	1.46
Quick Ratio	0.86
Debt / Equity	0.70
Debt / EBITDA	3.57
Debt / FCF	6.34
Interest Coverage	3.91

Financial Efficiency

Return on equity (ROE) is 5.30% and return on invested capital (ROIC) is 3.64%.

Return on Equity (ROE)	5.30%
Return on Assets (ROA)	2.91%
Return on Invested Capital (ROIC)	3.64%
Return on Capital Employed (ROCE)	5.72%
Revenue Per Employee	173,989
Profits Per Employee	5,518
Employee Count	111,513
Asset Turnover	0.58
Inventory Turnover	6.86

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +28.47% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+28.47%
50-Day Moving Average	47.26
200-Day Moving Average	42.99
Relative Strength Index (RSI)	53.49
Average Volume (20 Days)	559,910

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:FME had revenue of EUR 19.49 billion and earned 618.18 million in profits. Earnings per share was 2.11.

Revenue	19.49B
Gross Profit	4.77B
Operating Income	1.56B
Pretax Income	1.15B
Net Income	618.18M
EBITDA	2.36B
EBIT	1.56B
Earnings Per Share (EPS)	2.11

Balance Sheet

The company has 1.07 billion in cash and 10.84 billion in debt, giving a net cash position of -9.77 billion.

Cash & Cash Equivalents	1.07B
Total Debt	10.84B
Net Cash	-9.77B
Net Cash Per Share	n/a
Equity (Book Value)	15.50B
Book Value Per Share	48.98
Working Capital	2.51B

Cash Flow

In the last 12 months, operating cash flow was 2.42 billion and capital expenditures -711.22 million, giving a free cash flow of 1.71 billion.

Operating Cash Flow	2.42B
Capital Expenditures	-711.22M
Free Cash Flow	1.71B
FCF Per Share	n/a

Margins

Gross margin is 24.46%, with operating and profit margins of 8.00% and 3.17%.

Gross Margin	24.46%
Operating Margin	8.00%
Pretax Margin	5.90%
Profit Margin	3.17%
EBITDA Margin	12.12%
EBIT Margin	8.00%
FCF Margin	8.77%

Dividends & Yields

This stock pays an annual dividend of 1.44, which amounts to a dividend yield of 2.88%.

Dividend Per Share	1.44
Dividend Yield	2.88%
Dividend Growth (YoY)	21.01%
Years of Dividend Growth	1
Payout Ratio	56.48%
Buyback Yield	n/a
Shareholder Yield	2.88%
Earnings Yield	4.19%
FCF Yield	11.58%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 18, 2007. It was a forward split with a ratio of 3.

Last Split Date	Jun 18, 2007
Split Type	Forward
Split Ratio	3

Scores

FRA:FME has an Altman Z-Score of 1.74. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.74
Piotroski F-Score	n/a